We are live on ! Find out more
INDV icon

Indivior Pharmaceuticals
INDV

259 hedge funds and large institutions have $4.36B invested in Indivior Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 84 increasing their positions, 67 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,820% more call options, than puts

Call options by funds: $78M | Put options by funds: $4.07M

246% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 26

63% more capital invested

Capital invested by funds: $2.68B → $4.36B (+$1.68B)

31% more funds holding

Funds holding: 198 → 259 (+61)

25% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 67

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

Holders
259
Holders Change
+61
Holders Change %
+30.81%
% of All Funds
3.15%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
90
Increased
84
Reduced
67
Closed
26
Calls
$78M
Puts
$4.07M
Net Calls
+$74M
Net Calls Change
+$18.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$290M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$97.8M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$70.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$61.3M
5
State Street
State Street
Massachusetts
+$56.3M

Top Sellers

1
OCM
Oaktree Capital Management
California
-$7.65B
2
TSC
Two Seas Capital
New York
-$165M
3
DM
Deerfield Management
New York
-$110M
4
Goldman Sachs
Goldman Sachs
New York
-$104M
5
NM
Newtyn Management
New York
-$50.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
126
STRS Ohio
Ohio
$1.3M -$272K -8,900 -20%
Janus Henderson Group
127
Janus Henderson Group
United Kingdom
$1.29M -$1.25M -41,025 -53%
PCM
128
Polymer Capital Management
New York
$1.27M +$783K +25,632 +260%
SSA
129
Schonfeld Strategic Advisors
New York
$1.25M -$39.6K -1,297 -4%
Osaic Holdings
130
Osaic Holdings
Arizona
$1.22M +$1.03M +33,887 +30,806%
PFSRSONJ
131
Police & Firemen's Retirement System of New Jersey
New Jersey
$1.2M -$7.72K -253 -0.8%
Royal Bank of Canada
132
Royal Bank of Canada
Ontario, Canada
$1.15M -$2.15M -70,470 -69%
YCM
133
Yousif Capital Management
Michigan
$1.14M +$1.05M +34,497 New
Cetera Investment Advisers
134
Cetera Investment Advisers
Illinois
$1.11M -$589K -19,280 -38%
COPPSERS
135
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.11M +$944K +30,910 New
TRSOTSOK
136
Teachers Retirement System of the State of Kentucky
Kentucky
$1.1M +$937K +30,700 New
GC
137
Globeflex Capital
California
$1.09M +$707K +23,164 +326%
Canada Pension Plan Investment Board
138
Canada Pension Plan Investment Board
Ontario, Canada
$1.08M +$916K +30,000 New
ProShare Advisors
139
ProShare Advisors
Maryland
$1.05M +$121K +3,949 +16%
OPERF
140
Oregon Public Employees Retirement Fund
Oregon
$1.03M +$873K +28,600 New
NPT
141
National Philanthropic Trust
Pennsylvania
$999K +$850K +27,840 New
Mariner
142
Mariner
Kansas
$990K +$842K +27,585 New
DekaBank Deutsche Girozentrale
143
DekaBank Deutsche Girozentrale
Germany
$905K – – –
Two Sigma Advisers
144
Two Sigma Advisers
New York
$886K +$754K +24,700 New
ASRS
145
Arizona State Retirement System
Arizona
$876K -$156K -5,102 -17%
Sumitomo Mitsui Trust Group
146
Sumitomo Mitsui Trust Group
Japan
$807K -$235K -7,700 -26%
IC
147
IEQ Capital
California
$806K +$686K +22,468 New
Mirae Asset Global Investments
148
Mirae Asset Global Investments
South Korea
$797K +$234K +7,670 +53%
IAA
149
Independent Advisor Alliance
North Carolina
$791K +$673K +22,034 New
Daiwa Securities Group
150
Daiwa Securities Group
Japan
$785K -$516K -16,900 -44%
4 5
6
7 8

INDV Hedge Fund Activity: Q4 2025 in Review

259 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Indivior Pharmaceuticals (INDV) for Q4 2025, worth a combined $4.36B — up 63% from $2.68B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new INDV positions and 26 closed out — a net gain of 64 holders — while 84 added to existing stakes and 67 trimmed.

The largest buyer was BlackRock, adding an estimated $290M. The largest seller was Oaktree Capital Management, cutting an estimated $7.65B.

  • 259 institutional investors held Indivior Pharmaceuticals (INDV) as of Q4 2025, up from 198 in Q3 2025.
  • Funds reported $4.36B of Indivior Pharmaceuticals stock for Q4 2025, up 63% quarter-over-quarter.
  • 90 funds opened new Indivior Pharmaceuticals positions in Q4 2025 and 26 closed out, a net change of +64 holders.
  • The largest Indivior Pharmaceuticals buyer in Q4 2025 was BlackRock, an estimated $290M added.
  • The largest Indivior Pharmaceuticals seller in Q4 2025 was Oaktree Capital Management, an estimated $7.65B sold.

Based on aggregated 13F filings for Q4 2025.